• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

非洲区域灭活脊髓灰质炎疫苗及三价口服脊髓灰质炎疫苗/二价口服脊髓灰质炎疫苗转换情况介绍

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region.

作者信息

Tevi-Benissan Carol, Okeibunor Joseph, du Châtellier Gaël Maufras, Assefa Afework, Biey Joseph Nsiari-Muzenyi, Cheikh Dah, Eshetu Messeret, Anya Blanche-Philomene, Dao Halima, Nasir Yusuf, Akanmori Bartholomew Dicky, Mihigo Richard

机构信息

Immunization and Vaccines Development Programme, Family and Reproductive Health Cluster.

Polio Eradication Programme, Office of the Regional Director, World Health Organization (WHO) Regional Office for Africa, Brazzaville, Congo.

出版信息

J Infect Dis. 2017 Jul 1;216(suppl_1):S66-S75. doi: 10.1093/infdis/jiw616.

DOI:10.1093/infdis/jiw616
PMID:28838178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5853502/
Abstract

The Polio Eradication and Endgame Strategic plan outlines the phased removal of oral polio vaccines (OPVs), starting with type 2 poliovirus-containing vaccine and introduction of inactivated polio vaccine in routine immunization to mitigate against risk of vaccine-associated paralytic polio and circulating vaccine-derived poliovirus. The objective includes strengthening routine immunization as the primary pillar to sustaining high population immunity. After 2 years without reporting any wild poliovirus (July 2014-2016), the region undertook the synchronized switch from trivalent OPV (tOPV) to bivalent OPV (bOPV) as recommended by the Strategic Advisory Group of Experts on Immunization. Consequently the 47 countries of the World Health Organization (WHO) African Region switched from the use of tOPV to bOPV within the stipulated period of April 2016. Planning started early, routine immunization was strengthened, and technical and financial support was provided for vaccine registration, procurement, destruction, logistics, and management across countries by WHO in collaboration with the United Nations Children's Fund (UNICEF) and partners. National commitment and ownership, as well as strong coordination and collaboration between UNICEF and WHO and with partners, ensured success of this major, historic public health undertaking.

摘要

《脊髓灰质炎根除及终结战略计划》概述了分阶段停用口服脊髓灰质炎疫苗（OPV）的计划，首先停用含2型脊髓灰质炎病毒的疫苗，并在常规免疫中引入灭活脊髓灰质炎疫苗，以降低疫苗相关麻痹性脊髓灰质炎和循环疫苗衍生脊髓灰质炎病毒的风险。目标包括加强常规免疫，将其作为维持高人群免疫力的主要支柱。在连续两年未报告任何野生脊髓灰质炎病毒（2014年7月至2016年）之后，该地区按照免疫战略咨询专家组的建议，同步从三价OPV（tOPV）转换为二价OPV（bOPV）。因此，世界卫生组织（WHO）非洲区域的47个国家在2016年4月规定的期限内从使用tOPV转换为bOPV。规划工作提前启动，常规免疫得到加强，WHO与联合国儿童基金会（UNICEF）及合作伙伴协作，为各国的疫苗注册、采购、销毁、物流和管理提供技术和资金支持。国家的承诺和自主权，以及UNICEF与WHO之间以及与合作伙伴之间的强有力协调与合作，确保了这项重大的历史性公共卫生事业取得成功。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5b6/5853502/b0decdc24a2c/jiw61603.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5b6/5853502/2e13f88f522c/jiw61601.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5b6/5853502/a9814231d553/jiw61602.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5b6/5853502/b0decdc24a2c/jiw61603.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5b6/5853502/2e13f88f522c/jiw61601.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5b6/5853502/a9814231d553/jiw61602.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5b6/5853502/b0decdc24a2c/jiw61603.jpg

相似文献

1
Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region.非洲区域灭活脊髓灰质炎疫苗及三价口服脊髓灰质炎疫苗/二价口服脊髓灰质炎疫苗转换情况介绍
J Infect Dis. 2017 Jul 1;216(suppl_1):S66-S75. doi: 10.1093/infdis/jiw616.
2
Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective.实施从三价口服脊髓灰质炎疫苗到二价口服脊髓灰质炎疫苗的同步全球转换——全球视角下的经验教训
J Infect Dis. 2017 Jul 1;216(suppl_1):S183-S192. doi: 10.1093/infdis/jiw626.
3
Experience With Inactivated Polio Vaccine Introduction and the "Switch" From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization's Western Pacific Region.世界卫生组织西太平洋区域引入灭活脊髓灰质炎疫苗及从三价口服脊髓灰质炎疫苗“转换”为二价口服脊髓灰质炎疫苗的经验
J Infect Dis. 2017 Jul 1;216(suppl_1):S101-S108. doi: 10.1093/infdis/jiw574.
4
Communications, Immunization, and Polio Vaccines: Lessons From a Global Perspective on Generating Political Will, Informing Decision-Making and Planning, and Engaging Local Support.宣传、免疫与脊髓灰质炎疫苗：从全球视角看培养政治意愿、为决策与规划提供信息以及争取地方支持的经验教训
J Infect Dis. 2017 Jul 1;216(suppl_1):S24-S32. doi: 10.1093/infdis/jix059.
5
Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region.东地中海区域灭活脊髓灰质炎疫苗的引入、2型口服脊髓灰质炎疫苗的停用及常规免疫强化
J Infect Dis. 2017 Jul 1;216(suppl_1):S86-S93. doi: 10.1093/infdis/jix133.
6
Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas.美洲地区脊髓灰质炎灭活疫苗（IPV）引入及从三价口服脊髓灰质炎疫苗（tOPV）转换为二价口服脊髓灰质炎疫苗（bOPV）的系统化进程
J Infect Dis. 2017 Jul 1;216(suppl_1):S76-S85. doi: 10.1093/infdis/jiw557.
7
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.全球2型口服脊髓灰质炎疫苗同步停用的实施：意外使用三价口服脊髓灰质炎疫苗的风险
BMC Infect Dis. 2016 Jun 1;16:237. doi: 10.1186/s12879-016-1537-8.
8
Polio endgame: the global switch from tOPV to bOPV.脊髓灰质炎收官之战：全球从口服脊灰减毒活疫苗（tOPV）向口服二价脊灰减毒活疫苗（bOPV）的转换
Expert Rev Vaccines. 2016 Jun;15(6):693-708. doi: 10.1586/14760584.2016.1140041. Epub 2016 Feb 2.
9
Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.2013 - 2016年全球灭活脊髓灰质炎疫苗的引入及三价口服脊髓灰质炎疫苗向二价口服脊髓灰质炎疫苗的转换
MMWR Morb Mortal Wkly Rep. 2015 Jul 3;64(25):699-702.
10
India's Preparedness for Introduction of IPV and Switch from tOPV to bOPV.印度引入脊灰灭活疫苗以及从口服脊灰减毒活疫苗（tOPV）转换为二价口服脊灰减毒活疫苗（bOPV）的准备情况。
Indian Pediatr. 2016 Aug 7;53 Suppl 1:S44-S49.

引用本文的文献

1
Non-uptake of dual protective polio vaccine and its determinants among children in Ethiopia using Ethiopian Demographic Health Survey 2019: a mixed-effect model.利用2019年埃塞俄比亚人口与健康调查分析埃塞俄比亚儿童对双价脊髓灰质炎灭活疫苗的接种情况及其影响因素：混合效应模型
BMJ Open. 2024 Aug 31;14(8):e083648. doi: 10.1136/bmjopen-2023-083648.
2
Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey.利比里亚用新型口服 2 型脊灰病毒疫苗开展两轮运动后的脊灰病毒抗体：一项基于人群的集聚型血清阳性率调查。
Lancet Glob Health. 2023 Jun;11(6):e917-e923. doi: 10.1016/S2214-109X(23)00116-X.
3

本文引用的文献

1
Winning the battle against the scourge of poliomyelitis in the African Region.在非洲区域战胜脊髓灰质炎这一灾祸
Vaccine. 2016 Oct 10;34(43):5142-5143. doi: 10.1016/j.vaccine.2016.05.059. Epub 2016 Aug 27.
2
Contribution of polio eradication initiative to strengthening routine immunization: Lessons learnt in the WHO African region.根除脊髓灰质炎倡议对加强常规免疫的贡献：世卫组织非洲区域的经验教训
Vaccine. 2016 Oct 10;34(43):5187-5192. doi: 10.1016/j.vaccine.2016.05.062. Epub 2016 Jul 7.
3
Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries.
Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021.
2017-2021 年刚果民主共和国疫苗衍生脊髓灰质炎 2 型病毒引发的疫情和应对措施。
Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A35-A47. doi: 10.1016/j.vaccine.2023.02.042. Epub 2023 Mar 11.
4
Implementation challenges and real-world impacts of switching pediatric vaccines: A global systematic literature review.切换儿童疫苗的实施挑战和现实世界影响：全球系统文献回顾。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2177459. doi: 10.1080/21645515.2023.2177459. Epub 2023 Mar 7.
5
Response to back-to-back outbreaks of circulating vaccine-derived poliovirus type 2 in two nomadic pastoralist settlements in Oti Region, Ghana-2019.2019年加纳奥蒂地区两个游牧牧民定居点对2型循环疫苗衍生脊髓灰质炎病毒接连爆发的应对措施。
Arch Public Health. 2023 Jan 4;81(1):1. doi: 10.1186/s13690-022-01021-y.
6
The sensitivity of acute flaccid paralysis surveillance - the case of South Sudan: retrospective secondary analysis of AFP surveillance data 2014-2019.急性弛缓性麻痹监测的敏感性 - 以南苏丹为例：2014-2019 年 AFP 监测数据的回顾性二次分析。
Pan Afr Med J. 2022 Jun 11;42(Suppl 1):12. doi: 10.11604/pamj.supp.2022.42.1.33965. eCollection 2022.
7
Factors associated with the utilization of inactivated polio vaccine among children aged 12 to 23 months in Kalungu District, Uganda.乌干达卡伦古区12至23个月大儿童使用灭活脊髓灰质炎疫苗的相关因素。
Health Policy Plan. 2020 Nov 1;35(Supplement_1):i30-i37. doi: 10.1093/heapol/czaa099.
8
Validation of the bag-mediated filtration system for environmental surveillance of poliovirus in Nairobi, Kenya.验证袋式过滤系统在肯尼亚内罗毕进行环境脊髓灰质炎病毒监测的有效性。
J Appl Microbiol. 2021 Mar;130(3):971-981. doi: 10.1111/jam.14807. Epub 2020 Aug 14.
9
Progress Toward Poliomyelitis Eradication - Nigeria, January 2018-May 2019.迈向消灭脊髓灰质炎的进展 - 尼日利亚，2018 年 1 月至 2019 年 5 月。
MMWR Morb Mortal Wkly Rep. 2019 Jul 26;68(29):642-646. doi: 10.15585/mmwr.mm6829a3.
10
Concurrent assessment of epidemiological and operational uncertainties for optimal outbreak control: Ebola as a case study.同时评估流行病学不确定性和操作不确定性以实现最佳疫情控制：以埃博拉为例。
Proc Biol Sci. 2019 Jun 26;286(1905):20190774. doi: 10.1098/rspb.2019.0774. Epub 2019 Jun 19.
促进新型A群脑膜炎球菌结合疫苗在非洲脑膜炎带国家及时注册的监管途径。
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S428-33. doi: 10.1093/cid/civ491.
4
Polio eradication in the African Region on course despite public health emergencies.尽管面临突发公共卫生事件，非洲区域的脊髓灰质炎根除工作仍在按计划推进。
Vaccine. 2017 Mar 1;35(9):1202-1206. doi: 10.1016/j.vaccine.2015.08.024. Epub 2015 Aug 21.
5
Progress Toward Poliomyelitis Eradication--Nigeria, January 2014-July 2015.2014年1月至2015年7月尼日利亚在根除脊髓灰质炎方面取得的进展
MMWR Morb Mortal Wkly Rep. 2015 Aug 21;64(32):878-82. doi: 10.15585/mmwr.mm6432a5.
6
Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.2013 - 2016年全球灭活脊髓灰质炎疫苗的引入及三价口服脊髓灰质炎疫苗向二价口服脊髓灰质炎疫苗的转换
MMWR Morb Mortal Wkly Rep. 2015 Jul 3;64(25):699-702.
7
Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.2014年1月至2015年3月全球疫苗衍生脊髓灰质炎病毒最新情况
MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):640-6.
8
Meeting of the Strategic Advisory Group of Experts on immunization, April 2015: conclusions and recommendations.免疫战略咨询专家组会议，2015年4月：结论与建议
Wkly Epidemiol Rec. 2015 May 29;90(22):261-78.
9
Progress toward polio eradication - worldwide, 2014-2015.2014 - 2015年全球根除脊髓灰质炎进展情况
MMWR Morb Mortal Wkly Rep. 2015 May 22;64(19):527-31.
10
Possible eradication of wild poliovirus type 3--worldwide, 2012.2012年全球范围内3型野生脊髓灰质炎病毒可能被根除。
MMWR Morb Mortal Wkly Rep. 2014 Nov 14;63(45):1031-3.